First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device

Aortix™ is a novel percutaneous mechanical circulatory support device designed to facilitate diuresis in patients with cardiorenal syndrome. We describe for the first time the development of end-organ hypoperfusion from excess blood acceleration at the nominal setting and demonstrate through tempora...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajay Bhandari, Alden Dunham, Emmanuel Bassily, Bibhu D. Mohanty, Robby Wu
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2024/7430212
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849700404145684480
author Ajay Bhandari
Alden Dunham
Emmanuel Bassily
Bibhu D. Mohanty
Robby Wu
author_facet Ajay Bhandari
Alden Dunham
Emmanuel Bassily
Bibhu D. Mohanty
Robby Wu
author_sort Ajay Bhandari
collection DOAJ
description Aortix™ is a novel percutaneous mechanical circulatory support device designed to facilitate diuresis in patients with cardiorenal syndrome. We describe for the first time the development of end-organ hypoperfusion from excess blood acceleration at the nominal setting and demonstrate through temporal-perfusion marker curves, the potential for speed modulation to optimize results. This will inform future device development and investigation of patient-specific device titration.
format Article
id doaj-art-6c7fbd9656d841ee8d04a5d42844a02d
institution DOAJ
issn 2090-6412
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-6c7fbd9656d841ee8d04a5d42844a02d2025-08-20T03:18:17ZengWileyCase Reports in Cardiology2090-64122024-01-01202410.1155/2024/7430212First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ DeviceAjay Bhandari0Alden Dunham1Emmanuel Bassily2Bibhu D. Mohanty3Robby Wu4University of South FloridaUniversity of South FloridaUniversity of South FloridaUniversity of South FloridaUniversity of South FloridaAortix™ is a novel percutaneous mechanical circulatory support device designed to facilitate diuresis in patients with cardiorenal syndrome. We describe for the first time the development of end-organ hypoperfusion from excess blood acceleration at the nominal setting and demonstrate through temporal-perfusion marker curves, the potential for speed modulation to optimize results. This will inform future device development and investigation of patient-specific device titration.http://dx.doi.org/10.1155/2024/7430212
spellingShingle Ajay Bhandari
Alden Dunham
Emmanuel Bassily
Bibhu D. Mohanty
Robby Wu
First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
Case Reports in Cardiology
title First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
title_full First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
title_fullStr First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
title_full_unstemmed First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
title_short First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
title_sort first description of novel end organ effects by speed modulation using the aortix™ device
url http://dx.doi.org/10.1155/2024/7430212
work_keys_str_mv AT ajaybhandari firstdescriptionofnovelendorganeffectsbyspeedmodulationusingtheaortixdevice
AT aldendunham firstdescriptionofnovelendorganeffectsbyspeedmodulationusingtheaortixdevice
AT emmanuelbassily firstdescriptionofnovelendorganeffectsbyspeedmodulationusingtheaortixdevice
AT bibhudmohanty firstdescriptionofnovelendorganeffectsbyspeedmodulationusingtheaortixdevice
AT robbywu firstdescriptionofnovelendorganeffectsbyspeedmodulationusingtheaortixdevice